IL63423A0 - 9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them - Google Patents

9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them

Info

Publication number
IL63423A0
IL63423A0 IL63423A IL6342381A IL63423A0 IL 63423 A0 IL63423 A0 IL 63423A0 IL 63423 A IL63423 A IL 63423A IL 6342381 A IL6342381 A IL 6342381A IL 63423 A0 IL63423 A0 IL 63423A0
Authority
IL
Israel
Prior art keywords
hydroxyoctahydrobenzo
amino
pharmaceutical compositions
compositions containing
quinoline derivatives
Prior art date
Application number
IL63423A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL63423A0 publication Critical patent/IL63423A0/xx
Priority to IL72957A priority Critical patent/IL72957A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL63423A 1980-07-28 1981-07-27 9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them IL63423A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL72957A IL72957A0 (en) 1980-07-28 1984-09-14 9-oximino-1-hydroxyhexahydrobenzo(c)quinoline derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
IL63423A0 true IL63423A0 (en) 1981-10-30

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
IL63423A IL63423A0 (en) 1980-07-28 1981-07-27 9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them

Country Status (29)

Country Link
US (1) US4309545A (xx)
EP (1) EP0045171B1 (xx)
JP (1) JPS57112372A (xx)
KR (1) KR850000273B1 (xx)
AR (1) AR230988A1 (xx)
AT (1) ATE11775T1 (xx)
AU (1) AU525944B2 (xx)
CA (1) CA1178274A (xx)
CS (1) CS228515B2 (xx)
DD (1) DD202012A5 (xx)
DE (1) DE3168891D1 (xx)
DK (1) DK334581A (xx)
EG (1) EG15535A (xx)
ES (1) ES8301926A1 (xx)
FI (1) FI812338L (xx)
GR (1) GR75283B (xx)
GT (1) GT198170557A (xx)
HU (1) HU185133B (xx)
IE (1) IE51426B1 (xx)
IL (1) IL63423A0 (xx)
IN (1) IN158867B (xx)
NO (2) NO812557L (xx)
NZ (1) NZ197856A (xx)
PH (1) PH17281A (xx)
PL (1) PL133928B1 (xx)
PT (1) PT73440B (xx)
SU (1) SU1217254A3 (xx)
YU (1) YU185181A (xx)
ZA (1) ZA815128B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
CZ289340B6 (cs) * 1996-01-31 2002-01-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenanthridinové deriváty a farmaceutický prostředek s jejich obsahem
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
PT889886E (pt) * 1996-03-26 2003-02-28 Altana Pharma Ag Novas fenantridinas substituidas na posicao 6
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
AU9066498A (en) * 1997-07-25 1999-02-16 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted 6-alkylphenanthridines
ATE228507T1 (de) * 1997-07-25 2002-12-15 Altana Pharma Ag Substituierte 6-phenylphenanthridine
CN1561990A (zh) 1999-03-22 2005-01-12 免疫力药品有限公司 治疗免疫疾病
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
US20020137802A1 (en) * 2000-09-28 2002-09-26 Travis Craig R. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
CN1652766A (zh) * 2002-03-18 2005-08-10 免疫力药品有限公司 间苯二酚和大麻素的局部制剂及其施用方法
US20070254950A1 (en) * 2004-05-25 2007-11-01 Othera Pharmaceuticals, Inc. Oculoselective Drugs and Prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
HU180917B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás 5, 6, 6a, 7-tetrahidro-benzo [c] kinolin-9(8H)-on-származékok előállítására
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
PL133928B1 (en) 1985-07-31
AR230988A1 (es) 1984-08-31
CA1178274A (en) 1984-11-20
PT73440B (en) 1983-06-20
SU1217254A3 (ru) 1986-03-07
FI812338L (fi) 1982-01-29
AU525944B2 (en) 1982-12-09
GT198170557A (es) 1983-01-12
PL232331A1 (en) 1983-09-26
EP0045171A3 (en) 1982-04-28
ATE11775T1 (de) 1985-02-15
EP0045171A2 (en) 1982-02-03
PT73440A (en) 1981-08-01
ZA815128B (en) 1982-07-28
KR830006217A (ko) 1983-09-20
NO812557L (no) 1982-01-29
GR75283B (xx) 1984-07-13
KR850000273B1 (ko) 1985-03-15
DD202012A5 (de) 1983-08-24
HU185133B (en) 1984-12-28
IN158867B (xx) 1987-02-07
NO854454L (no) 1985-01-29
IE51426B1 (en) 1986-12-24
JPS57112372A (en) 1982-07-13
NZ197856A (en) 1984-10-19
DE3168891D1 (en) 1985-03-28
IE811686L (en) 1982-01-28
AU7343481A (en) 1982-05-06
YU185181A (en) 1983-12-31
EP0045171B1 (en) 1985-02-13
ES504323A0 (es) 1982-12-16
PH17281A (en) 1984-07-06
CS228515B2 (en) 1984-05-14
DK334581A (da) 1982-01-29
EG15535A (en) 1986-09-30
ES8301926A1 (es) 1982-12-16
US4309545A (en) 1982-01-05

Similar Documents

Publication Publication Date Title
HK31885A (en) 2-hydroxy-5-phenylazobenzoic acid derivatives and pharmaceutical compositions containing them
IL73877A (en) Quinolone derivatives and pharmaceutical compositions containing them
IL75326A0 (en) Quinolone derivatives and pharmaceutical compositions containing them
IL61936A (en) Derivatives of cba2 and pharmaceutical compositions containing them
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
IL63423A0 (en) 9-amino-1-hydroxyoctahydrobenzo(c)quinoline derivatives and pharmaceutical compositions containing them
DE3168067D1 (en) 2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions containing them
GB2088373B (en) Dibenzazepine derivatives and pharmaceutical compositions containing them
IL64054A0 (en) Imidazolylpyridines and pharmaceutical compositions containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
PH18532A (en) Novel carbostyril derivatives and pharmaceutical compositions containing the same
IL64544A (en) Quinolone derivatives,their preparation and pharmaceutical compositions containing them
NZ198414A (en) Quinolone derivatives and pharmaceutical compositions
NZ190245A (en) Isoquinoline derivatives and pharmaceutical compositions containing them
GB2079285B (en) Dipthosphonate derivatives and pahrmaceutical compositions containing them
PH15118A (en) Octahydro-2h-pyrrolo(3-4-g)quinolines pharmaceutical composition containing same
JPS56139481A (en) Quinoline derivative and medicinal composition containing same
IL61038A (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
IL60695A0 (en) Hexahydro-trans-pyridoindole derivatives and pharmaceutical compositions containing them
PT72890B (en) Bis-hydroxybenzyl derivatives processes for their preparation and pharmaceutical compositions containing same
IL62146A (en) Guanylamidines and pharmaceutical compositions containing them
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
IL60332A0 (en) Pyridylaminotriazole derivatives and pharmaceutical compositions containing them
IL63699A0 (en) Pharmaceutical compositions comprising pyridine derivatives and certain such novel compounds